Dr. Kirsten A. Grüneberg is a co-founder of the Grüneberg and Myers law firm and represents many of the world’s largest chemical, biotech, and pharmaceutical companies, including US Fortune 50 and Global Fortune 200 companies in Japan and Europe. She has successfully defended high value pharma patents in post-grant proceedings, helping to secure business deals worth several hundreds of millions of dollars. Dr. Grüneberg also has significant experience in Hatch-Waxman related matters as well as IP issues in connection with mergers and acquisitions in the U.S., Germany, Switzerland, Japan and China. Dr. Grüneberg is active in the areas of opinions and counseling, post-grant proceedings including inter partes review and reexaminations, intellectual property portfolio management and development, chemical as well as pharmaceutical/medical devices patent prosecution.
Year Joined Firm: 2017
Education/Alumni:
- J.D., George Washington University School of Law
- Ph.D., Organic Chemistry, magna cum laude, Technische Universität Berlin, Germany
- M.S., Organic Chemistry, summa cum laude, E-M-Arndt-Universität, Germany
- B.S., Chemistry/Chemical Engineering, magna cum laude, E-M-Arndt-Universität, Germany
Network Memberships: VPP, AIPLA, LESI
Last updated 18th May 2020
